Abtak Logo

recombinant-dna News

Stay updated with the latest recombinant-dna news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on recombinant-dna topics.

fallback-img
soure image
30
HealthApr 03, 2026 01:04 PM

Emcure Pharma Reduces Poviztra® Starting Dose Price by 55% to Expand Patient Access - APN News | Aut...

Bangalore : Emcure Pharmaceuticals Ltd., (BSE: 544210, NSE: EMCURE) has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses). The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple admini ...Read More >

News Nation English - Other - News Image
soure image
5
OtherAug 22, 2025 10:04 PM

DCGI alerts doctors, health professionals on theft of multiple drug products of Novo Nordisk

New Delhi [India], August 22 (ANI): India drug regulator has alerted on the theft of multiple drug products of Novo Nordisk during transit. According to the notice issued by the Drugs Controller General of India (DCGI), Dr Rajeev Raghuvanshi, Mis Novo Nordisk has informed about a theft of its products, as mentioned below, during transit from its Bhiwandi Hub to milk route (Nagpur, Raipur, Cuttack, and Kolkata). The DCGI has also mentioned in the notice that the quality of the injectables is re ...Read More >

NewsDrum - Business - News Image
soure image
18
BusinessAug 12, 2025 01:10 PM

Lupin ties up with Sandoz to commercialise biosimilar product

New Delhi, Aug 12 (PTI) Drug firm Lupin on Tuesday said it has partnered with Switzerland-based Sandoz Group AG to commercialise its biosimilar ranibizumab across multiple regions. Under the terms of the agreement, Sandoz will oversee commercialisation of the product across the European Union (excluding Germany), Switzerland, Norway, Australia, Hong Kong, Vietnam, and Malaysia, the Mumbai-based drug maker said in a statement. Lupin will be responsible for manufacturing the product and for regu ...Read More >

ThePrint - Other Politics Sports Business Environment - News Image
soure image
3

Sreeshankar wins long jump title in Portugal

New Delhi, Jul 20 (PTI) Star Indian long jumper Murali Sreeshankar clinched the title with a leap of 7.75m at the Meeting Maia Cidade do Desporto in Maia, Portugal, a World Athletics Continental Tour Bronze-level meet. The Asian Games silver medallist registered his best effort in the second round on Saturday night. Sreeshankar opened with a 7.63m jump, followed it up with his winning leap of 7.75m in the second round, and then recorded a solid 7.69m. His third attempt was a foul, while his fi ...Read More >

News Nation English - Other - News Image
soure image
36
OtherJul 20, 2025 12:36 PM

Development of indigenous multi-stage Malaria vaccine 'AdFalciVax' is underway

New Delhi [India], July 20 (ANI): The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax. AdFalciVax is the first indigenous recombinant chimeric malaria vaccine specifically designed to target tw ...Read More >

The Tribune - Politics - News Image
soure image
20
PoliticsJul 20, 2025 12:31 PM

Development of indigenous multi-stage Malaria vaccine AdFalciVax is underway - The Tribune

New Delhi [India], July 20 (ANI): The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax. AdFalciVax is the first indigenous recombinant chimeric malaria vaccine specifically designed to target tw ...Read More >

Unknown Source - Politics - News Image
source image
26
PoliticsJul 20, 2025 02:44 AM

ICMR to transfer tech for production of malaria vaccine | Bhubaneswar News - Times of India

Bhubaneswar: The Indian Council of Medical Research (ICMR), New Delhi, on Thursday invited expressions of interest from eligible organisations, companies, and manufacturers for undertaking the 'transfer of technology' for commercialisation of a malaria vaccine developed by ICMR-Regional Medical Research Centre (RMRC), Bhubaneswar.This technology, "A recombinant chimeric multi-stage malaria vaccine (AdFalciVax) against Plasmodium falciparum", is useful in preventing Plasmodium falciparum infectio ...Read More >

ThePrint - Politics Business Entertainment - News Image
soure image
22
PoliticsBusinessEntertainmentJul 20, 2025 02:21 AM

ICMR invites EoIs for commercial production of advanced malaria vaccine

New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >

LatestLY - Politics - News Image
soure image
31
PoliticsJul 20, 2025 01:04 AM

India News | ICMR Invites EoIs for Commercial Production of Advanced Malaria Vaccine | LatestLY

New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >

The Times of India - Other Politics Sports Business Technology - News Image
soure image
15

ICMR invites EoIs for commercial production of advanced malaria vaccine

New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >

The Times of India - Other Politics Sports Business - News Image
soure image
18
OtherPoliticsSportsBusinessJul 20, 2025 12:21 AM

Analysts slam India for not resolving Kashmir issue so far

Dr. Mujahid Gilani (Senior Kashmiri Leader): Long before 14 August 1947, people of Jammu and Kashmir had voted in favour of Pakistan even before the division of Sub-Continent. They gave their decision over vehemently to become to join Pakistan as its Muslim majority province. In the backdrop of global situation, we must realize that people of Jammu and Kashmir are struggling for maintaining their lives. Their ratio of population in Jammu and Kashmir which was over 98 % in 1947 has been reduced a ...Read More >

LatestLY - Health - News Image
soure image
16
HealthJul 01, 2025 08:27 AM

India News | BE to Manufacture HPV9 Vaccine for India, UNICEF and PAHO Tender Markets | LatestLY

Hyderabad (Telangana) [India], July 1 (ANI): Jiangsu Recbio Technology Company Limited (02179.HK), announced that they have entered into a licensing cooperation agreement, and have commenced the technology transfer of their Recombinant 9-valent HPV (HPV9) vaccine, REC603, to Biological E. Limited (BE), a leading Indian vaccine and pharmaceutical company. Recbio will provide BE with Drug Substance (DS) and transfer technology to formulate, fill, and package vaccines. It will also include technolo ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.